PENNYGATE MEDICAL CENTRE — All Prescriptions & Medications — Page 14

Practice Code: P92016 | WIGAN, WN2 2QG

Showing results 651-700 of 809

MedicationItems (12m) ↓QuantityCostvs National
20484£1.7K+201.8% ▲
201,800£318-49.1% ▼
20300£1.5K+120.0% ▲
Levomepromazine maleate19916£7.8K+106.9% ▲
Clomipramine hydrochloride191,708£266-54.9% ▼
Metformin hydrochloride/sitagliptin191,400£242-49.2% ▼
Triptorelin1919£3.9K-9.9% ▼
Other phosphate supplement preparations191,600£302+211.4% ▲
Other compound vitamin/mineral formulation preparations19780£97-40.7% ▼
Ready to serve 2.4 kcal/ml milkshake higher volume (0913011)19108.0K£657-6.1% ▼
Pyridostigmine bromide194,200£331+11.0% ▲
Travoprost1983£53-59.7% ▼
Tafluprost19750£305+2.5% ▲
Menthol195,700£214-32.5% ▼
Tars195,475£341+126.7% ▲
19440£681+219.9% ▲
193,350£94+47.3% ▲
1952£962+45.3% ▲
19780£1.5K+48.5% ▲
19940£3.3K+148.5% ▲
Fondaparinux sodium18360£2.3K+370.9% ▲
Flupentixol decanoate18152£2.3K+12.8% ▲
Fosfomycin trometamol1819£88-36.7% ▼
Prasterone18644£349+172.7% ▲
Exemestane18540£95-44.6% ▼
Ready to serve 1.5 kcal/ml milkshake with fibre (0913021)18163.2K£4.3K+30.4% ▲
Fluorometholone18110£36+25.0% ▲
Ciclosporin (Eye Anti Inflammatory)18690£1.7K-27.4% ▼
18320£983+195.5% ▲
18190£429+14.7% ▲
18392£830-44.7% ▼
1854£1.0K+135.3% ▲
18109£232+9.1% ▲
182,040£6.9K+25.8% ▲
181,776£126-34.5% ▼
Oxazepam17798£82-20.2% ▼
Doxycycline monohydrate17568£317+56.6% ▲
Saxagliptin17952£1.0K-49.1% ▼
Betamethasone sodium phosphate171,404£184+38.3% ▲
Lidocaine17510£56+259.3% ▲
Calcitriol172,400£412+220.2% ▲
Malathion173,150£287+166.2% ▲
1717£533+97.9% ▲
1747£840+67.5% ▲
17510£220-34.8% ▼
17440£3.1K+34.1% ▲
Naldemedine16448£634+82.2% ▲
Diltiazem hydrochloride16480£196+245.4% ▲
Opicapone16636£1.3K-16.4% ▼
Isophane insulin1695£412-84.8% ▼
← Back to PENNYGATE MEDICAL CENTRE
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.